involvement of the ~l.B T-cell antigen receptor in cytotoxicity mediated bv human alloantigen specific -cell clones.
Mo~:e than half a decade after their identification, "r~ T cells continue to challen~e immunologists. Their antigenic specificity, antigen recognition process and biological role are still largely elusive. Paradoxically, increased frequencies of "1"8 T cells can be found in two apparently polar situations: immunodeficiency on the one hand, and hyperimmune states such as autoimmunity and inflammatory conditions on the other hand. The hypothesis presented here postulates that "I,8 T cells, vital remnants of a primitive cellular immune system, are called upon in situations where the more evolutionarily advanced and "sophisticated" cellular immune barrier, the a[3 T-cell-dependent system, is failing. Under certain circumstances, this may result in autoimmunity.
It has long been noticed that immunodeficiency and autoimmunity, two apparently conflicting clinical situations, can co-exist. For example, patients with agammaglobulinaemia have a higher frequency of arthritis clinically indistinguishable from rheumatoid arthritis (RA) (Good et al., 1957) . Patients with selective IgA deficiency have a greater than expected occurrence of systemic lapus erythematosus (Cassidy et al., 1969) and insulin-dependent dia-betes mellitus (Hoddincot et al., 1982) , Autoimmune phenomena have also been observed in patients with AIDS (Kopelman and Zolla-Pazner~ 1988; Berman et al., 1988) . In addition, rodents rendered immunodeficient by cyclosporine A, by to,~al lymphoid irradiation or by anti-T-cell antibodies may develop autoimmune sequelae (Trentham et ai., 1984; Sakuguchi and Sakaguchi, 1988, 1989) .
T cells bearing the -f8 T-cell receptor (TCR) have been identified in higher frequencies in spontaneous or induced immunodeficiencies. Patients with ataxia teleangiectasia, a syndrome associated with immunodeficiency, have been reported to display a high frequency of "r8 T cells in their peripheral blood (Carbonari et al., 1990 ). In addition, some patients with Wiskott-Aldrich syndrome and severe combined immunodeficiency have up to 68 % circulating -f8 T cells (Morio et al., 1990) . Long-term "t8 T-cell lines were isolated from a patient with immunodeficiency (Brenner et al., 1987) . lmmunodeficiency induced by cyclospofine A in mice is associated with a relative increase in "T' cells (Jenkins eC at., 1988) . Taken together, the above observations may suggest that inherent or acquired defects in development or functie~ of TCR 0t[3 cells may create suitable conditions for less "sophisticated", potentially autoaggressive ccEs, such as TCR -f~ cells, to expand and result in autoimmunity.
Could "spontaneously" occurring autoimmune conditions which have no clinically apparent immu~odeficiency, such as RA, stem from a similar pathogenetic mechanism ? TCR -f~ cells and cells with the phenotype CD3 J CD4-CD8 -("double-negative" cells, which are mostly TCR "t'8 cells) have been implicated in a number of hyperimmune conditions in mice including models of lupus (Datta et ai., 1987) and autoreactivity (Morriset et al., 1988) . Double-negative murine T cells were found capabP, of breaking oral tolerance (Kitamura et al., 1987) . In humans, double-negative cells have been found in thyroid tissue in Hashimoto thyroiditis (Del Prete et ai., 1986) .
Abe',dance of double-negative TCR ~8 cells has also been noticed in the lungs of patients with sarcoidosis (Balbi et al., 1990) and in the synovial fluid of patients with RA (De Maria et al., 1987 ; Brennan et al., 1988a; Haynes et al., 1988; Holoshitz et al., 1989; Reme et al., 1990 ).
The role of -f8 T cells in the pathogenesis of RA has not been defined yet. However, a number of observations sug~,est that they may be pathogenically important. T cells in general are thought to play an important role in the pathogenesis of RA. Histologically, the synovial membrane in RA is infiltrated by T lymphocytes, predominantly of the CD4 + phenotype. These T cells show markers of activation sucl-: as receptors for IL-2 and HLA class II molecules (Klareskog et al., 1982) . Selective elimination of CD4+ T cells by procedures such as total lymphoid irradiation (Tanay et al., 1987) can lead to improvement of the disease. The specificity of synovial T cells is unknown. While an antigennon-specific T-cell activation may play a role in perpetuation of the disease (Haynes et al., 1988) , the close association of RA with certain HLA DR alleles suggests that recognition of an arthritogenic antigen may be involved in triggering the disease. Two-thirds of patients with seropositire RA display the HLA DR4 phenotype (Stastny, 1978) . Consistent with the "shared epitope" theory (Gregersen et al., 1987) , recent molecular data suggest that many of the remaining one-third of DR4-negative patients may share with the DR4-positives a typical nucleotide sequence at the third hypervariable region of the DR[31 gene (Nepom et al., 1989) . This region of the class II [3 chain is predicted to comprise part of the class II helix critical for specific interaction with antigenic peptides and the TCR (Brown et al., 1988) . Mutations in this region have been shown to alter T-cell immune responses and susceptibility to ~,utoimmune disease in mice (Christadoss et al., 1985) . Thus, it is conceivable that susceptibility to RA is related to the ability of these regions to present antigens to T cells.
As mentioned above, the identity of the putative antigen is still unknown. However, the possibility that mycobacterial heat shock proteins (HSP) are playing a role is emerging. Synovial T lymphocytes from patients with RA make a vigorous proliferative response to mycobacterial antigen, in particular to the 65-Kda mycobacterial HSP (Holoshitz et al., 1986; Reset al., 1988) . These studies have shown that the proliferative responses to the mycobacterial protein were higher in synovial fluids than those in paired peripheral blood. The reactivity was characteristically found in early stages of joint inflammation, suggesting that T-cell reactivity to HSP may be involved in triggering the arthritis. Additional evidence for the potential arthritogenicity of HSP comes from studies of adjuvant arthritis, a rat model of RA. From rats afflicted with this disease, a T-cell line (Holoshitz et al., 1983) and clones (Holoshitz et al., 1984 (Holoshitz et al., , 1988 ) capable of either transferring or protecting against arthritis have been isolated. These clones recognize an epitope within amino adds 180-188 of the mycobacterial 65-kDa HSP .
HSP are a family of highly conserved proteins which can be induced in nrnlc~rvntlr and ~nknrvnt;~ ~llc hL. h~at or other stress conditions. While their biological role is not entirely understood, these findings have fostered the idea that antigenic mimicry might be involved in the pathogenesis of RA and other inflammatory arthritic conditions. According to this hypothesis, gcnetica!!y susceptible individuals may develop an immune response to bacterial HSP that is cross-reactive with self. The resultant immune injury to target cells may in turn induce further expression of HSP and lead to, chronic self perpetuation of the disease. However, it is possible that the reactivity of synovial T cells to mycobacterial proteins is an effect of the disease rather than a cause. It is possible that tissue injury in a variety of inflammatory arthritic conditions, regardless of the precipitating initial events, results in expression of new antigens on the synovial cell mrface which cross-react with the mycobacterial antigens.
Given the close association between certain DR alleles and RA susceptibility, it would seem reasonable to predict that recognition of a specific antigen in the joint by at[~ T cells would involve a clonally restricted population of T cells. An increasing body of evidence suggests that this is probably not the case. Initial studies using Southern blot analysis of TCR [3 genes showed distinct rearrangements in long-term cultured synovial T cells, suggesting clonal dominance (Stamenkovic et al., 1988) . However, the possibility that the long term tissue culture conditions in that study could have induced in vitro selection was suggested by the finding of similar clonai dominance in cultures obtained from patients with osteoarthritis (Stamenkovic et al., 1988) . Moreover, recent studies failed to demonstrate [3-chain gene rearrangement in any one of 15 fresh synoviai fluid cell preparations from RA patients (Keystone et al., 1988) or predominant rearrangements among 40 RA synovial fluid T-cell clones (Duby et al., 1989) . Other recent studies reached similar conclusions (Savill et al., 1987; Brennan et al., 1988b) . Although these results question the clonality of a[3 T cells in RA synovial effusions, they do not exclude the role of antigen-specific T-cell responses in RA. It is possible that different TCR are capable of recognizing one or more epitopes on the target antigen. It is also possible that a small minority of antigen-specific T-cell clones initiate an autoaggressive process which can be perpetuated by recruitment and activation of a polyclonal T-cell population. These results provide a rationale for directing mere attention to T8 T cells.
As mentioned above, synovial effusions of RA patients contain a high number of T cells bearing the T8 TCR. Their percentage in synovial effusions was found to be between ,:wo-fold to four-fold that in normal peripheral blood. Furthermore, in some of these studies (Brennan et al., 1988a; Holoshitz et aL, 1989; Reme et al., 1990) , most, if not all, of the T~ T cells stained positively with the monoclonal antibody Ti -TA, which detects TCR T chains with the particular rearrangement: VT9JTPCTI (Triebel el al., 1988) .
Thus, while there is no evidence for a[3 clonality, a -f~ T-cell population, possibly oligoclonal, preferentially accumulates in RA synovial fluids. It is quite interesting that peripheral TCR "f~ T cells and TCR -f8 cells isolated from synovial fluid and thymus were found to recognize mycobacterial antigens, including the mycobacterial 65-kDa HSP (Hoioshitz et al., 1989; Janis et aL, 1989; O'Brien et aL, 1989; Haregewoin et aL, 1989; Modlin et al., 1989; Kabelitz et al., 1990) . With one exception (Haregewoin et al., 1989) , all studies have shown that reactivity of ~,8 T cells to mycobacteria was MHCunrestricted. Studies of the structure of the TCR chains of mycobacteriareactive T-cell clones revealed a limited receptor repertoire. For example, human lnycobacteria-reactive -f~ T-cell clones were found to uniformly express the V~'9J-fPC-fl rearrangement, paired with V82-bearing TCR 8 chain (Holoshitz et al., 1989; Kabelitz et al., 1990; Holoshitz et al., unpublished results) , and murine mycobacteriareactive "i'~ T cells all expressed the V-rlJC-r4 rearrangement paired with a V86-bearing 8 chain . Limited V-region usage and MHC nonrestricted recognition of mycobacteria are reminiscent of bacterial "superantigen" recognition by el3 cells. Recent results from the author's laboratory indicate that, in addition to their reactivity to the mycobacterial superantigen-like moeity, 3'8 T cells can recognize nominal antigenic peptides (Holoshitz et al., in preparation) .
The basic hypothesis presented here is that TCR T8 cells and perhaps other "immature" cells play a role in triggering the synovitis of RA. It is hypothesized that RA-susceptible individuals cannot raise an adequate T-cell response to certain foreign antigens due to holes iv their a[3 T-cell repertoire. Patients with RA have been found to display an impaired immune response to EBV tDepper and Zvaifler, !981) and tetanus toxoid (Devey et al., 1987) . In the case of EBV, sequence homology between the EBV glycoproteill gpll0 and the third hypervariable region of the RAassociated DR[31 chain was noticed (Roudier et al., 1988) . It is hypothesized that a number of potential RA-inciting antigens might have sequence homology with either the "bare" DR[31 chain or with a combination of DRI31 and a self peptide occupying the MHC groove. Due to self tolerance, these antigens would not be recognized by a[3 T cells. Instead, they will be presented to -f8 T cells by a relatively nonpolymorphic RA-associated MHC molecule such as DRw53 (Merryman et al., 1989) or by another non-MHC molecule in linkage disequilibrium with DR4. (Experimental data supporting such nominal antigen recognition are currently being accumulated in the author's laboratory.)
The vast majority of indiv duals with DR alleles that confer suscel~tibility to RA do not develop arthritis. In a small minority of individuals, this otherwise safe and effective "1"8 T-cell immune response may result in RA due to other, non-MHC genes (Go et al., 1987) . Such putative polymorphic genes may encode products capable of enhancivg activation of "t'~ T cells and/or migration of these cells to the, ....
--. E,,,, organs. The accumulation of -f8 T cells in the synovium may be due to in situ activation by either the nominal antigen, the mycobacterial superantigen, or self consti!uent_s of ......... the joint mimicking those, . unt~g~zils. 1 ne locally acuvateo "fo 1 Ceils could release lymphokines capable of polyclonal activation of a[3 T cells (Ferrick et al., 1989) and stimulation of macrophages (Modlin et ai., 1989) , leading to the formation of a pannus. While 3,8 T cells would have a role in triggering the inflammatory process, according to this hypothesis, the effector role is played by polyclonal CD4 ÷ T cells. Elimination of such cells has been reported to yield temporary relief of RA (Tanay et al., 1987) .
In summary, it is hypothesized that ~-8 T cells are used as an alternative defence mechanism in situations of 0t[~ T-cell-dependent immunodeficiency. An analogous situation of "limited immunodcficiency" may exist in RA when, due to their amiho acid sequence homology to the DRI3 chain, some ffreign antigens are tolerated by 0tl3 1-cells. The impaired immune defence against the foreign antigen is partially compensated by activated y8 T cells. The -fB T-cell response, augmented with the aid of non-MHC gene products, may result in arthritis. This hypothesis is not free of pitfalls; however, it offers a plausible explanation to some puzzling questions regarding RA and possibly other autoimmune conditions. It is conceivable that similar constellations of certain MHC alleles, foreign antigens and conducive non-MHC genes can be implicated in other MHC-associated au~ toimmune diseases.
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